CHIROPRACTORS COMMENCE SPINAL HEALTH MONTH WITH RESEARCH IN MENTAL HEALTH Promising results in clinical study integrating routine physical care with online psychological therapies
With
Dr Kim Lie Jom, Chiropractor
Chatswood, New South Wales &
Board Director
Australian Chiropractors Association (ACA)
Alex Malley, Chief Executive Officer,
Australian Chiropractors Association (ACA)
Dr Aimee Mason, Chiropractor
Sydney, New South Wales &
Chair, Eastern Regional Committee,
Australian Chiropractors Association
Dr David McNaughton PhD (Psychology),
Chiropractor
Chatswood, New South Wales &
Senior Lecturer, Central Queensland University
SEGMENT
Filmed in Sydney | June 2026
A new Australian-first clinical research study has found promising results for reducing the mental health impacts of chronic musculoskeletal pain by combining online psychological therapies with routine physical care. The research, funded by the Australian Chiropractors Association (ACA) and conducted through CQUniversity and Macquarie University’s MindSpot programme, highlights the strong connection between chronic pain and mental wellbeing.
The findings are supported by a national survey of 1,040 Australians, which revealed that 66.4% of people experiencing back pain say it has negatively affected their mental health. The survey also found that chronic pain lasting more than three months has increased significantly, rising from 30% of Australians in 2024 to 44.1% in 2026.
Cost-of-living pressures are also affecting healthcare access, with 44% of back pain sufferers reporting they cannot afford treatment. As a result, visits to healthcare professionals have declined while reliance on over-the-counter pain medication has increased.
Back pain affects an estimated 6.1 million Australians and costs the economy approximately $55.1 billion each year. With musculoskeletal conditions projected to grow by 43% over the next two decades, the findings underscore the need for integrated approaches to physical and mental health care.
The research coincides with National Spinal Health Month in June 2026, which marks the 30th anniversary of the ACA’s spinal health campaign and promotes the theme: “A healthy spine supports a healthy mind.”
Source: Adapted from ACA Media Release (May 2026)
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
-
AHW Exhibitor: Health Professionals Bank
Healthcare professionals recently had a new bank enter the market. Health Professionals Bank owned by Teachers Mutual Bank, commenced operations in February this year aiming to be a member owned bank that “Cares for those who care”. Exhibiting at Australian Healthcare Week in Sydney last week, General Manager Carolyn Murphy spoke with Australian Health Journal reporter, Anne Dao
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
